4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-017597
Chief Executive Officer sold 5,675 shares at $202.54 ($1,149,410)
- Chief Executive Officer acquired 5,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farrell Michael J. Chief Executive Officer | 2022-06-15 | Option exercise | +5,675 | $57.76 | $327,788 | 410,935 | D |
| Farrell Michael J. Chief Executive Officer | 2022-06-15 | Sale | −5,675 | $202.54 | $1,149,410 | 405,260 | D |
| Derivatives | |||||||
| Farrell Michael J. Chief Executive Officer | 2022-06-15 | Option exercise · ResMed Common Stock Options | −5,675 | 99,940 | D | ||
| Open-market sales · 5,675 sh · avg $202.54 · $1,149,410 | |||||||
Loading xslF345X03/form4.xml…